The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Certification and role of local pathologists for diffuse large B-cell lymphoma (DLBCL) subtyping and eligibility determination in the phase II PYRAMID study.
Jonathan W. Said
Other Remuneration - Millennium
James Andrew Reeves
No relevant relationships to disclose
Ian Flinn
Research Funding - Millennium
Anil Tulpule
No relevant relationships to disclose
Robert Leon Robles
No relevant relationships to disclose
Christopher Flowers
Consultant or Advisory Role - Allos Therapeutics; Celgene; Genentech (U); Millennium (U); Roche (U); Seattle Genetics; Spectrum Pharmaceuticals
Research Funding - Millennium; Novartis; Spectrum Pharmaceuticals
Nicholas J. DiBella
No relevant relationships to disclose
Kathryn S. Kolibaba
Research Funding - Pharmacyclics
Parameswaran Venugopal
No relevant relationships to disclose
Tatjana Kolevska
No relevant relationships to disclose
Sven De Vos
Honoraria - Millennium
Research Funding - Millennium
David L. Jaye
Honoraria - Millennium
Dixie Esseltine
Employment or Leadership Position - Millennium
Stock Ownership - Takeda
George Mulligan
Employment or Leadership Position - Millennium
Stock Ownership - Millennium
Maria Margarita Corvez
Employment or Leadership Position - Millennium
Stock Ownership - Millennium
John R. Eckardt
Consultant or Advisory Role - DAVAOncology
Bryan Brockman
Consultant or Advisory Role - DAVAOncology
Isagani M. Chico
No relevant relationships to disclose
John Leonard
Consultant or Advisory Role - Millennium
Honoraria - Millennium
Steven Kussick
Employment or Leadership Position - PhenoPath Laboratories
Stock Ownership - PhenoPath Laboratories